EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genetic regulatory axis between AGR2 and ESR1 promotes breast cancer progression

M Aiman Mohtar iD, Delphine Fessart iD, Chia Yuh Cai iD, Syazalina Zahari, Saiful Effendi Syafruddin, Muhammad-Redha Abdullah-Zawawi iD, Valerie Le Morvan, Said Taouji, Ted Hupp

PLOS One · 01.07.2026 · 21 (7) · e0351873

DOI: 10.1371/journal.pone.0351873 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, online erschienen am 01.07.2026. Verfasst von M Aiman Mohtar und 8 weiteren Autor:innen. Beteiligte Einrichtung: UKM Medical Molecular Biology Institute (UMBI), Universiti Kebangsaan Malaysia, Jalan Yaacob Latiff, Kuala Lumpur, Malaysia. Hauptthemen laut MEDLINE: Estrogen Receptor alpha, Mucoproteins, Breast Neoplasms, Gene Expression Regulation, Neoplastic. Die Arbeit nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ministry of higher education malaysia, The France-Malaysia Collaboration Programme for Joint Research, Geran Pembiayaan Sepadan-Dana Padanan Kolaborasi.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Anterior gradient protein 2 (AGR2), a member of the protein disulfide isomerase family, plays a critical role in endoplasmic reticulum proteostasis and has been implicated in breast cancer progression. However, the downstream regulatory programs and signaling pathways governed by AGR2 remain incompletely defined. Here, we employed CRISPR–Cas9-mediated knockout of AGR2 in breast cancer cells to systematically investigate the functional and transcriptional consequences of AGR2 loss. AGR2 depletion resulted in significant suppression of cell migration, invasion, and chemoresistance. Unbiased transcriptomic profiling by RNA sequencing revealed extensive differential gene expression, implicating AGR2 in receptor-mediated signaling, oxidative stress responses, and cell adhesion pathways. Protein–protein interaction network analysis identified several highly connected hub genes within the AGR2-regulated transcriptome, including estrogen receptor alpha (ESR1/ERα), cadherin 1 (CDH1), androgen receptor (AR), lymphocyte cell-specific protein-tyrosine kinase (LCK), S100 calcium binding protein P (S100P), parkin RBR E3 ubiquitin ligase (PRKN), and decay-accelerating factor (CD55). Notably, ERα emerged as a prominent node within this network, consistent with prior reports linking ERα and AGR2 biology. Integration with publicly available epigenomic datasets further supports a potential regulatory connection between ERα-associated chromatin landscapes and AGR2 expression. Together, these findings define AGR2-dependent transcriptional networks in breast cancer and identify ESR1-associated signaling as a key pathway perturbed upon AGR2 loss, providing a foundation for future mechanistic studies targeting this regulatory interaction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Estrogen Receptor alphaMucoproteinsBreast NeoplasmsGene Expression Regulation, NeoplasticHumansOncogene ProteinsFemaleCell Line, TumorDisease ProgressionCell MovementSignal TransductionGene Expression Profiling

Substanzen

AGR2 protein, humanEstrogen Receptor alphaOncogene ProteinsMucoproteinsESR1 protein, human

Autor:innen und Institutionen

  • UKM Medical Molecular Biology Institute (UMBI), Universiti Kebangsaan Malaysia, Jalan Yaacob Latiff, Kuala Lumpur, Malaysia.
  • ARTiSt Group, University of Bordeaux, INSERM U1312, Institut Bergonie, 229 Cours de l'Argonne, Bordeaux, France.
  • Institute of Genetics and Cancer, MRC Institute of Genetics & Molecular Medicine, University of Edinburgh, Edinburgh, Scotland, United Kingdom.

ORCID-Profile: M Aiman Mohtar, Delphine Fessart, Chia Yuh Cai, Muhammad-Redha Abdullah-Zawawi

Förderung

  • ministry of higher education malaysia
  • The France-Malaysia Collaboration Programme for Joint Research
  • Geran Pembiayaan Sepadan-Dana Padanan Kolaborasi

Zitieren

APA

Mohtar, M. A., Fessart, D., Yuh Cai, C., Zahari, S., Syafruddin, S. E., Abdullah-Zawawi, M. R., Le Morvan, V., Taouji, S., & Hupp, T. (2026). Genetic regulatory axis between AGR2 and ESR1 promotes breast cancer progression. PLOS One, 21(7), e0351873. https://doi.org/10.1371/journal.pone.0351873

Vancouver

Mohtar MA, Fessart D, Yuh Cai C, Zahari S, Syafruddin SE, Abdullah-Zawawi MR, et al. Genetic regulatory axis between AGR2 and ESR1 promotes breast cancer progression. PLOS One. 2026;21(7):e0351873. doi:10.1371/journal.pone.0351873

BibTeX
@article{Mohtar2026,
  author = {Mohtar, M Aiman and Fessart, Delphine and Yuh Cai, Chia and Zahari, Syazalina and Syafruddin, Saiful Effendi and Abdullah-Zawawi, Muhammad-Redha and Le Morvan, Valerie and Taouji, Said and Hupp, Ted},
  title = {Genetic regulatory axis between AGR2 and ESR1 promotes breast cancer progression},
  journal = {PLOS One},
  year = {2026},
  volume = {21},
  number = {7},
  pages = {e0351873},
  doi = {10.1371/journal.pone.0351873}
}
Kostenlos starten →